BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boziki M, Sintila SA, Ioannidis P, Grigoriadis N. Biomarkers in Rare Demyelinating Disease of the Central Nervous System. Int J Mol Sci 2020;21:E8409. [PMID: 33182495 DOI: 10.3390/ijms21218409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Plastini MJ, Desu HL, Ascona MC, Lang AL, Saporta MA, Brambilla R. Transcriptional abnormalities in induced pluripotent stem cell-derived oligodendrocytes of individuals with primary progressive multiple sclerosis. Front Cell Neurosci 2022;16:972144. [DOI: 10.3389/fncel.2022.972144] [Reference Citation Analysis]
2 Deng RX, Wu YJ, Xu LP, Liu KY, Huang XJ, Zhang XH. Clinical risk factors and prognostic model for idiopathic inflammatory demyelinating diseases after haploidentical hematopoietic stem cell transplantation in patients with hematological malignancies. Am J Hematol 2021;96:1407-19. [PMID: 34350623 DOI: 10.1002/ajh.26312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bax BE. Biomarkers in Rare Diseases. Int J Mol Sci 2021;22:E673. [PMID: 33445477 DOI: 10.3390/ijms22020673] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]